曼月乐联合子宫内膜去除术可降低 heavy menstrual bleeding 患者子宫切除风险
Adding a Mirena IUD during surgery can reduce the risk of hysterectomy in women with heavy menstrual bleeding
一项多中心开放标签随机对照试验显示,曼月乐(Mirena)联合子宫内膜去除术可降低 heavy menstrual bleeding 患者两年内子宫切除需求(4% vs 10%)。
原文明确给出联合治疗与子宫切除风险降低的统计学证据,读者可据此对比现有治疗方案的循证依据。
Fitting a hormonal intrauterine device (IUD) during surgery to help manage heavy menstrual bleeding reduces a woman's risk of needing a hysterectomy in the following two years by more than half, according to a new open-label randomized controlled trial published in The Lancet.
Heavy periods affect about 30% of women of reproductive age in European countries and can disrupt work, school and everyday activities. One common treatment is endometrial ablation, an operation that removes the lining of the uterus to stop or greatly reduce menstrual bleeding. However, about 1 in 10 women who undergo this procedure still need a hysterectomy within two years. The MIRA2 trial tested whether fitting a hormonal IUD during an endometrial ablation could reduce the need for a hysterectomy in the future.
Researchers followed 715 women at 34 hospitals in the Netherlands for two years: half had an IUD fitted during their ablation and half did not. The IUD was inserted into the womb immediately after the ablation was completed. After two years, about 4% of the women who had an IUD fitted had needed a hysterectomy, compared with 10% of those who had ablation alone.
Women given an IUD also experienced other health benefits. At six months, more women given an IUD had stopped having periods altogether (59% versus 46%). Over the two-year follow-up, fewer participants in the combined-treatment group needed additional medication to control their bleeding (6% versus 16%), and at two years fewer reported cyclical period pain (17% versus 25%).
The authors say offering a hormonal IUD insertion to women undergoing endometrial ablation could prevent more women from needing a future hysterectomy and provide them with better control of bleeding and period pain. However, they add that the possibility of side effects, which were commonly reported and could lead to discontinuation of IUD use, should be included in patient counseling.
Publication details
Tamara J Oderkerk et al., Endometrial ablation plus levonorgestrel-releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding in The Netherlands (MIRA2): a multicentre, open-label, randomised, controlled, superiority trial, The Lancet (2026). DOI: 10.1016/s0140-6736(26)01536-9
Journal information: The Lancet
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Adding a Mirena IUD during surgery can reduce the risk of hysterectomy in women with heavy menstrual bleeding (2026, October 22) retrieved 22 October 2026 from https://medicalxpress.com/news/2026-10-adding-mirena-iud-surgery-hysterectomy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com